Capital Allocation

United Therapeutics Forges Ahead with Share Repurchases, Not Dividends, Following July 2025 Volume Surge

United Therapeutics

United Therapeutics Forges Ahead with Share Repurchases, Not Dividends, Following July 2025 Volume Surge

In a financial landscape often fixated on consistent dividend payouts, United Therapeutics Corporation (NASDAQ: UTHR) stands out with a distinct capital allocation strategy. Contrary to market discussions about "dividend increases," the biotechnology firm has publicly stated it does not anticipate paying dividends in the immediate future. Instead, the

By MarketMinute
Europe's Value Revolution: Billions Flow from Overpriced US Equities to Undervalued European Bargains

Financial Markets

Europe's Value Revolution: Billions Flow from Overpriced US Equities to Undervalued European Bargains

A notable capital reallocation is underway in global financial markets, with investors increasingly pulling funds from the United States and channeling them into European equities throughout 2025. This significant shift is primarily driven by the compelling valuation differential between the two regions; European stocks are perceived as significantly undervalued, offering

By MarketMinute